440 related articles for article (PubMed ID: 1664803)
1. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
2. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
Perren MJ; Feniuk W; Humphrey PP
Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.
Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR
Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
Nishimura Y
Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
Dreteler GH; Wouters W; Saxena PR
Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.
Parsons AA; Whalley ET; Feniuk W; Connor HE; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):434-40. PubMed ID: 2538194
[TBL] [Abstract][Full Text] [Related]
7. Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery.
MacLean MR; Clayton RA; Templeton AG; Morecroft I
Br J Pharmacol; 1996 Sep; 119(2):277-82. PubMed ID: 8886409
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery.
Seager JM; Clark AH; Garland CJ
Br J Pharmacol; 1992 Feb; 105(2):424-8. PubMed ID: 1532763
[TBL] [Abstract][Full Text] [Related]
9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
10. Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat.
Dreteler GH; Wouters W; Toorop GP; Jansen JA; Saxena PR
J Cardiovasc Pharmacol; 1991 Mar; 17(3):488-93. PubMed ID: 1711612
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
[TBL] [Abstract][Full Text] [Related]
12. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro.
Dupont LJ; Pype JL; Demedts MG; De Leyn P; Deneffe G; Verleden GM
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1479-86. PubMed ID: 9817696
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries.
Parsons AA; Whalley ET
Eur J Pharmacol; 1989 Dec; 174(2-3):189-96. PubMed ID: 2560978
[TBL] [Abstract][Full Text] [Related]
14. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.
Connor HE; Feniuk W; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):379-87. PubMed ID: 2538191
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
17. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.
Manuel NA; Wallis DI; Crick H
Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984
[TBL] [Abstract][Full Text] [Related]
18. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-hydroxytryptamine receptors on the isolated pig basilar artery by functional and radioligand binding studies.
Miyamoto A; Sakota T; Nishio A
Jpn J Pharmacol; 1994 Jul; 65(3):265-73. PubMed ID: 7799527
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
